Lefkofsky teams up with Rush hospital
October 31st, 2016
Eric Lefkfosky’s Tempus technology company is teaming up with Rush University Medical Center in a project that uses data and analytics to help doctors customize treatment for cancer patients. It’s the latest collaboration in the tech entrepreneur’s quest to cure cancer.
“Technology has come a long way since the human genome was first mapped more than 15 years ago, but many cancer patients are still being treated with a one-size-fits-all approach that may not fit the specific molecular composition of their cancer,” Lefkofsky says in a release. The Tempus CEO knows a lot about data. He co-founded Groupon, a tech company that found success in analyzing online clicks.
Now Lefkofsky’s zeroing in on cancer. His company uses “genomic sequencing” and analyzes molecular and therapeutic data that physicians use to make decisions about cancer treatments.
Tempus has also teamed up with Northwestern University’s Lurie Comprehensive Cancer Center, the University of Michigan and a clinical trial group at University of Chicago.